SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-055455
Filing Date
2018-10-17
Accepted
2018-10-17 19:43:11
Documents
2
Period of Report
2018-10-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14341
2 POA DOCUMENT poa.txt EX-24.3_813996 3919
  Complete submission text file 0001209191-18-055455.txt   19874
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Issuer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY DRIVE, SUITE 30 MALVERN PA 19355
Business Address
Arnold Susan Elizabeth (Reporting) CIK: 0001755746 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38697 | Film No.: 181127361